Vesicles as carriers of virulence factors in parasitic protozoan diseases

Microbes and Infection

Volumn 14, Issue 15, 2012, Pages 1465-1474

  Torrecilhas, Ana Claudia ^a   Schumacher, Robert I ^b   Alves, Maria Júlia M ^b   Colli, Walter ^b  

^a FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

^b UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Pathogenic protozoan parasites; Vesicles; Virulence factors

Indexed keywords

PARASITE ANTIGEN; VIRULENCE FACTOR;

AFRICAN TRYPANOSOMIASIS; APICOMPLEXA; ARTICLE; CELL METABOLISM; CHEMICAL COMPOSITION; HOST CELL; HUMAN; LEISHMANIA; MEMBRANE VESICLE; NONHUMAN; PARASITE PHENOMENA AND FUNCTIONS; PARASITE SHEDDING; PARASITOSIS; PRIORITY JOURNAL; TRYPANOSOMA CRUZI; TRYPANOSOMIASIS;

ANIMALS; APICOMPLEXA; EXOSOMES; HOST-PARASITE INTERACTIONS; HUMANS; PROTOZOAN INFECTIONS; TRYPANOSOMATINA; VIRULENCE FACTORS;

APICOMPLEXA; PROTOZOA; TRYPANOSOMATIDAE;

EID: 84870827127     PISSN: 12864579     EISSN: 1769714X     Source Type: Journal    
DOI: 10.1016/j.micinf.2012.07.008     Document Type: Article

References (101)

1. Schorey J.S., Bhatnagar S. Exosome function: from tumor immunology to pathogen biology. Traffic 2008, 9:871-881.
2. Thery C., Ostrowski M., Segura E. Membrane vesicles as conveyors of immune responses. Nat.Rev. Immunol. 2009, 9:581-593.
3. Thery C. Exosomes: secreted vesicles and intercellular communications. F1000 Biol. Rep. 2011, 3:15.
4. Mathivanan S., Fahner C.J., Reid G.E., Simpson R.J. ExoCarta 2012: database of exosomal proteins, RNA and lipids. Nucleic Acids Res. 2012, 40:D1241-D1244.
5. Thery C., Zitvogel L., Amigorena S. Exosomes: composition, biogenesis and function. Nat. Rev. Immunol. 2002, 2:569-579.
6. Trams E.G., Lauter C.J., Salem N., Heine U. Exfoliation of membrane ecto-enzymes in the form of micro-vesicles. Biochim. Biophys. Acta. 1981, 645:63-70.
7. Pan B.T., Teng K., Wu C., Adam M., Johnstone R.M. Electron microscopic evidence for externalization of the transferrin receptor in vesicular form in sheep reticulocytes. J. Cell Biol. 1985, 101:942-948.
8. Record M., Subra C., Silvente-Poirot S., Poirot M. Exosomes as intercellular signalosomes and pharmacological effectors. Biochem. Pharmacol. 2011, 81:1171-1182.
9. Gasser O., Schifferli J.A. Activated polymorphonuclear neutrophils disseminate anti-inflammatory microparticles by ectocytosis. Blood 2004, 104:2543-2548.
10. Eken C., Gasser O., Zenhaeusern G., Oehri I., Hess C., Schifferli J.A. Polymorphonuclear neutrophil-derived ectosomes interfere with the maturation of monocyte-derived dendritic cells. J. Immunol. 2008, 180:817-824.
11. Thery C., Boussac M., Veron P., Ricciardi-Castagnoli P., Raposo G., Garin J., Amigorena S. Proteomic analysis of dendritic cell-derived exosomes: a secreted subcellular compartment distinct from apoptotic vesicles. J. Immunol. 2001, 166:7309-7318.
12. Gyorgy B., Szabo T.G., Pasztoi M., Pal Z., Misjak P., Aradi B., Laszlo V., Pallinger E., Pap E., Kittel A., Nagy G., Falus A., Buzas E.I. Membrane vesicles, current state-of-the-art: emerging role of extracellular vesicles. Cell Mol. Life Sci. 2011, 68:2667-2688.
13. Valadi H., Ekstrom K., Bossios A., Sjostrand M., Lee J.J., Lotvall J.O. Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells. Nat. Cell. Biol. 2007, 9:654-659.
14. Izquierdo-Useros N., Naranjo-Gomez M., Archer J., Hatch S.C., Erkizia I., Blanco J., Borras F.E., Puertas M.C., Connor J.H., Fernandez-Figueras M.T., Moore L., Clotet B., Gummuluru S., Martinez-Picado J. Capture and transfer of HIV-1 particles by mature dendritic cells converges with the exosome-dissemination pathway. Blood 2009, 113:2732-2741.
15. Bobrie A., Colombo M., Raposo G., Thery C. Exosome secretion: molecular mechanisms and roles in immune responses. Traffic 2011, 12:1659-1668.
16. Chaput N., Thery C. Exosomes: immune properties and potential clinical implementations. Semin. Immunopathol 2011, 33:419-440.
17. Krishnamoorthy L., Bess J.W., Preston A.B., Nagashima K., Mahal L.K. HIV-1 and microvesicles from T cells share a common glycome, arguing for a common origin. Nat. Chem. Biol. 2009, 5:244-250.
18. Batista B.S., Eng W.S., Pilobello K.T., Hendricks-Munoz K.D., Mahal L.K. Identification of a conserved glycan signature for microvesicles. J. Proteome Res. 2011, 10:4624-4633.
19. Goncalves M.F., Umezawa E.S., Katzin A.M., de Souza W., Alves M.J., Zingales B., Colli W. Trypanosoma cruzi: shedding of surface antigens as membrane vesicles. Exp. Parasitol. 1991, 72:43-53.
20. Ouaissi A., Aguirre T., Plumas-Marty B., Piras M., Schoneck R., Gras-Masse H., Taibi A., Loyens M., Tartar A., Capron A., et al. Cloning and sequencing of a 24-kDa Trypanosoma cruzi specific antigen released in association with membrane vesicles and defined by a monoclonal antibody. Biol. Cell. 1992, 75:11-17.
21. Pinho R.T., Vannier-Santos M.A., Alves C.R., Marino A.P., Castello Branco L.R., Lannes-Vieira J. Effect of Trypanosoma cruzi released antigens binding to non-infected cells on anti-parasite antibody recognition and expression of extracellular matrix components. Acta. Trop. 2002, 83:103-115.
22. Affranchino J.L., Ibanez C.F., Luquetti A.O., Rassi A., Reyes M.B., Macina R.A., Aslund L., Pettersson U., Frasch A.C. Identification of a Trypanosoma cruzi antigen that is shed during the acute phase of Chagas' disease. Mol. Biochem. Parasitol. 1989, 34:221-228.
23. Ferguson M.A. The structure, biosynthesis and functions of glycosylphosphatidylinositol anchors, and the contributions of trypanosome research. J. Cell. Sci. 1999, 112(Pt 17):2799-2809.
24. Guha-Niyogi A., Sullivan D.R., Turco S.J. Glycoconjugate structures of parasitic protozoa. Glycobiology 2001, 11:45R-59R.
25. Almeida I.C., Gazzinelli R.T. Proinflammatory activity of glycosylphosphatidylinositol anchors derived from Trypanosoma cruzi: structural and functional analyses. J. Leukoc. Biol. 2001, 70:467-477.
26. Colli W. Trans-sialidase: a unique enzyme activity discovered in the protozoan Trypanosoma cruzi. Faseb J. 1993, 7:1257-1264.
27. Almeida I.C., Camargo M.M., Procopio D.O., Silva L.S., Mehlert A., Travassos L.R., Gazzinelli R.T., Ferguson M.A. Highly purified glycosylphosphatidylinositols from Trypanosoma cruzi are potent proinflammatory agents. Embo J. 2000, 19:1476-1485.
28. Brodskyn C., Patricio J., Oliveira R., Lobo L., Arnholdt A., Mendonca-Previato L., Barral A., Barral-Netto M. Glycoinositolphospholipids from Trypanosoma cruzi interfere with macrophages and dendritic cell responses. Infect. Immun. 2002, 70:3736-3743.
29. Chuenkova M.V., Furnari F.B., Cavenee W.K., Pereira M.A. Trypanosoma cruzi trans-sialidase: a potent and specific survival factor for human Schwann cells by means of phosphatidylinositol 3-kinase/Akt signaling. Proc. Natl. Acad. Sci. U.S. A 2001, 98:9936-9941.
30. Magdesian M.H., Giordano R., Ulrich H., Juliano M.A., Juliano L., Schumacher R.I., Colli W., Alves M.J. Infection by Trypanosoma cruzi. Identification of a parasite ligand and its host cell receptor. J. Biol. Chem. 2001, 276:19382-19389.
31. Ouaissi A., Ouaissi M. Molecular basis of Trypanosoma cruzi and Leishmania interaction with their host(s): exploitation of immune and defense mechanisms by the parasite leading to persistence and chronicity, features reminiscent of immune system evasion strategies in cancer diseases. Arch. Immunol. Ther. Exp. (Warsz) 2005, 53:102-114.
32. Buscaglia C.A., Alfonso J., Campetella O., Frasch A.C. Tandem amino acid repeats from Trypanosoma cruzi shed antigens increase the half-life of proteins in blood. Blood 1999, 93:2025-2032.
33. Leguizamon M.S., Mocetti E., Garcia Rivello H., Argibay P., Campetella O. Trans-sialidase from Trypanosoma cruzi induces apoptosis in cells from the immune system in vivo. J. Infect. Dis. 1999, 180:1398-1402.
34. Tribulatti M.V., Mucci J., Van Rooijen N., Leguizamon M.S., Campetella O. The trans-sialidase from Trypanosoma cruzi induces thrombocytopenia during acute Chagas' disease by reducing the platelet sialic acid contents. Infect. Immun. 2005, 73:201-207.
35. Csete M., Lev B.I., Pereira M.E. An influenza virus model for Trypanosoma cruzi infection: interactive roles for neuraminidase and lectin. Curr. Top. Microbiol. Immunol. 1985, 117:153-165.
36. Marroquin-Quelopana M., Oyama S., Aguiar Pertinhez T., Spisni A., Aparecida Juliano M., Juliano L., Colli W., Alves M.J. Modeling the Trypanosoma cruzi Tc85-11 protein and mapping the laminin-binding site. Biochem. Biophys. Res. Commun. 2004, 325:612-618.
37. Giordano R., Fouts D.L., Tewari D., Colli W., Manning J.E., Alves M.J. Cloning of a surface membrane glycoprotein specific for the infective form of Trypanosoma cruzi having adhesive properties to laminin. J. Biol. Chem. 1999, 274:3461-3468.
38. Yoshida N., Tyler K.M., Llewellyn M.S. Invasion mechanisms among emerging food-borne protozoan parasites. Trends Parasitol. 2011, 27:459-466.
39. Almeida I.C., Ferguson M.A., Schenkman S., Travassos L.R. Lytic anti-alpha-galactosyl antibodies from patients with chronic Chagas' disease recognize novel O-linked oligosaccharides on mucin-like glycosyl-phosphatidylinositol-anchored glycoproteins of Trypanosoma cruzi. Biochem. J. 1994, 304(Pt 3):793-802.
40. De Marchi C.R., Di Noia J.M., Frasch A.C., Amato Neto V., Almeida I.C., Buscaglia C.A. Evaluation of a recombinant Trypanosoma cruzi mucin-like antigen for serodiagnosis of Chagas' disease. Clin. Vaccine Immunol. 2011, 18:1850-1855.
41. Campos M.A., Almeida I.C., Takeuchi O., Akira S., Valente E.P., Procopio D.O., Travassos L.R., Smith J.A., Golenbock D.T., Gazzinelli R.T. Activation of toll-like receptor-2 by glycosylphosphatidylinositol anchors from a protozoan parasite. J. Immunol. 2001, 167:416-423.
42. Ropert C., Almeida I.C., Closel M., Travassos L.R., Ferguson M.A., Cohen P., Gazzinelli R.T. Requirement of mitogen-activated protein kinases and I kappa B phosphorylation for induction of proinflammatory cytokines synthesis by macrophages indicates functional similarity of receptors triggered by glycosylphosphatidylinositol anchors from parasitic protozoa and bacterial lipopolysaccharide. J. Immunol. 2001, 166:3423-3431.
43. Trocoli Torrecilhas A.C., Tonelli R.R., Pavanelli W.R., da Silva J.S., Schumacher R.I., de Souza W., E Silva NC., de Almeida Abrahamsohn I., Colli W., Manso Alves M.J. Trypanosoma cruzi: parasite shed vesicles increase heart parasitism and generate an intense inflammatory response. Microbes Infect. 2009, 11:29-39.
44. Frasch A.C. Functional diversity in the trans-sialidase and mucin families in Trypanosoma cruzi. Parasitol. Today 2000, 16:282-286.
45. Acosta-Serrano A., Almeida I.C., Freitas-Junior L.H., Yoshida N., Schenkman S. The mucin-like glycoprotein super-family of Trypanosoma cruzi: structure and biological roles. Mol. Biochem. Parasitol. 2001, 114:143-150.
46. Almeida I.C., Ferguson M.A., Schenkman S., Travassos L.R. GPI-anchored glycoconjugates from Trypanosoma cruzi trypomastigotes are recognized by lytic anti-alpha-galactosyl antibodies isolated from patients with chronic Chagas' disease. Braz. J. Med. Biol. Res. 1994, 27:443-447.
47. Aparicio I.M., Scharfstein J., Lima A.P. A new cruzipain-mediated pathway of human cell invasion by Trypanosoma cruzi requires trypomastigote membranes. Infect. Immun. 2004, 72:5892-5902.
48. Nakayasu E., Almeida I.C. Proteomics studies in Trypanosoma cruzi. Bioinformatics in Tropical Disease Research. A Practical and Case-Study Approach 2008, NBK6289. National Center for Biotechnological Information, Bethesda MD. A.M.D. Arthur Gruber, C. Huynh, H.A. del Portillo (Eds.).
49. Frevert U., Schenkman S., Nussenzweig V. Stage-specific expression and intracellular shedding of the cell surface trans-sialidase of Trypanosoma cruzi. Infect. Immun. 1992, 60:2349-2360.
50. Brun R., Blum J., Chappuis F., Burri C. Human African trypanosomiasis. Lancet 2010, 375:148-159.
51. Smith D.H., Pepin J., Stich A.H. Human African trypanosomiasis: an emerging public health crisis. Br. Med. Bull. 1998, 54:341-355.
52. McCulloch R. Antigenic variation in African trypanosomes: monitoring progress. Trends Parasitol. 2004, 20:117-121.
53. Pays E., Vanhamme L., Perez-Morga D. Antigenic variation in Trypanosoma brucei: facts, challenges and mysteries. Curr. Opin. Microbiol. 2004, 7:369-374.
54. Kieft R., Capewell P., Turner C.M., Veitch N.J., MacLeod A., Hajduk S. Mechanism of Trypanosoma brucei gambiense (group 1) resistance to human trypanosome lytic factor. Proc. Natl. Acad. Sci. U. S. A 2010, 107:16137-16141.
55. Namangala B., Noel W., De Baetselier P., Brys L., Beschin A. Relative contribution of interferon-gamma and interleukin-10 to resistance to murine African trypanosomosis. J. Infect. Dis. 2001, 183:1794-1800.
56. Grab D.J., Garcia-Garcia J.C., Nikolskaia O.V., Kim Y.V., Brown A., Pardo C.A., Zhang Y., Becker K.G., Wilson B.A., de A.L.A.P., Scharfstein J., Dumler J.S. Protease activated receptor signaling is required for African trypanosome traversal of human brain microvascular endothelial cells. PLoS Negl. Trop. Dis. 2009, 3:e479.
57. Grab D.J., Chakravorty S.J., van der Heyde H., Stins M.F. How can microbial interactions with the blood-brain barrier modulate astroglial and neuronal function?. Cell. Microbiol. 2011, 13:1470-1478.
58. Baetselier P.D., Namangala B., Noel W., Brys L., Pays E., Beschin A. Alternative versus classical macrophage activation during experimental African trypanosomosis. Int. J. Parasitol. 2001, 31:575-587.
59. Atyame Nten C.M., Sommerer N., Rofidal V., Hirtz C., Rossignol M., Cuny G., Peltier J.B., Geiger A. Excreted/secreted proteins from trypanosome procyclic strains. J. Biomed. Biotechnol. 2010, 2010:212817.
60. Garzon g.A.E., Totte P., Regnier C., Cuny G., Dedieu L. Infectology VII Meeting 2006, S171, Col1-SFP, Trypanosoma brucei Secrete Factors Able To Inhibit Dendritic Cells Maturation And Their Ability To Induce Lymphocytic Allogenic Responses, Infectiology VII Meeting 2006, pp. S171.
61. Geiger A., Hirtz C., Becue T., Bellard E., Centeno D., Gargani D., Rossignol M., Cuny G., Peltier J.B. Exocytosis and protein secretion in Trypanosoma. BMC. Microbiol. 2010, 10:20.
62. WHO Control of the Leishmaniases, WHO Technical Report Series 949 2010, pp.187.
63. Duthie M.S., Raman V.S., Piazza F.M., Reed S.G. The development and clinical evaluation of second-generation leishmaniasis vaccines. Vaccine 2012, 30:134-141.
64. Tuladhar R., Natarajan G., Satoskar A.R. Role of co-stimulation in Leishmaniasis. Int. J. Biol. Sci. 2011, 7:1382-1390.
65. Teixeira M.J., Teixeira C.R., Andrade B.B., Barral-Netto M., Barral A. Chemokines in host-parasite interactions in leishmaniasis. Trends Parasitol. 2006, 22:32-40.
66. Sacks D., Noben-Trauth N. The immunology of susceptibility and resistance to Leishmania major in mice. Nat. Rev. Immunol. 2002, 2:845-858.
67. Silverman J.M., Clos J., de'Oliveira C.C., Shirvani O., Fang Y., Wang C., Foster L.J., Reiner N.E. An exosome-based secretion pathway is responsible for protein export from Leishmania and communication with macrophages. J. Cell Sci. 2010, 123:842-852.
68. Peters N.C., Sacks D.L. The impact of vector-mediated neutrophil recruitment on cutaneous leishmaniasis. Cell. Microbiol. 2009, 11:1290-1296.
69. van Zandbergen G., Klinger M., Mueller A., Dannenberg S., Gebert A., Solbach W., Laskay T. Cutting edge: neutrophil granulocyte serves as a vector for Leishmania entry into macrophages. J. Immunol. 2004, 173:6521-6525.
70. Silverman J.M., Chan S.K., Robinson D.P., Dwyer D.M., Nandan D., Foster L.J., Reiner N.E. Proteomic analysis of the secretome of Leishmania donovani. Genome Biol. 2008, 9:R35.
71. Nandan D., Yi T., Lopez M., Lai C., Reiner N.E. Leishmania EF-1alpha activates the Src homology 2 domain containing tyrosine phosphatase SHP-1 leading to macrophage deactivation. J. Biol. Chem. 2002, 277:50190-50197.
72. Halle M., Gomez M.A., Stuible M., Shimizu H., McMaster W.R., Olivier M., Tremblay M.L. The Leishmania surface protease GP63 cleaves multiple intracellular proteins and actively participates in p38 mitogen-activated protein kinase inactivation. J. Biol. Chem. 2009, 284:6893-6908.
73. Somanna A., Mundodi V., Gedamu L. Functional analysis of cathepsin B-like cysteine proteases from Leishmania donovani complex. Evidence for the activation of latent transforming growth factor beta. J. Biol. Chem. 2002, 277:25305-25312.
74. Gantt K.R., Schultz-Cherry S., Rodriguez N., Jeronimo S.M., Nascimento E.T., Goldman T.L., Recker T.J., Miller M.A., Wilson M.E. Activation of TGF-beta by Leishmania chagasi: importance for parasite survival in macrophages. J. Immunol. 2003, 170:2613-2620.
75. Ma D., Russell D.G., Beverley S.M., Turco S.J. Golgi GDP-mannose uptake requires Leishmania LPG2. A member of a eukaryotic family of putative nucleotide-sugar transporters. J. Biol. Chem. 1997, 272:3799-3805.
76. Silverman J.M., Clos J., Horakova E., Wang A.Y., Wiesgigl M., Kelly I., Lynn M.A., McMaster W.R., Foster L.J., Levings M.K., Reiner N.E. Leishmania exosomes modulate innate and adaptive immune responses through effects on monocytes and dendritic cells. J. Immunol. 2010, 185:5011-5022.
77. Schnitzer J.K., Berzel S., Fajardo-Moser M., Remer K.A., Moll H. Fragments of antigen-loaded dendritic cells (DC) and DC-derived exosomes induce protective immunity against Leishmania major. Vaccine 2010, 28:5785-5793.
78. Offeddu V., Thathy V., Marsh K., Matuschewski K. Naturally acquired immune responses against Plasmodium falciparum sporozoites and liver infection. Int. J. Parasitol. 2012, 42:535-548.
79. Brossier F., Jewett T.J., Sibley L.D., Urban S. A spatially localized rhomboid protease cleaves cell surface adhesins essential for invasion by Toxoplasma. Proc. Natl. Acad. Sci. U. S. A 2005, 102:4146-4151.
80. O'Donnell R.A., Hackett F., Howell S.A., Treeck M., Struck N., Krnajski Z., Withers-Martinez C., Gilberger T.W., Blackman M.J. Intramembrane proteolysis mediates shedding of a key adhesin during erythrocyte invasion by the malaria parasite. J. Cell. Biol. 2006, 174:1023-1033.
81. Blackman M.J., Scott-Finnigan T.J., Shai S., Holder A.A. Antibodies inhibit the protease-mediated processing of a malaria merozoite surface protein. J. Exp. Med. 1994, 180:389-393.
82. Baker R.P., Wijetilaka R., Urban S. Two Plasmodium rhomboid proteases preferentially cleave different adhesins implicated in all invasive stages of malaria. PLoS Pathog. 2006, 2:e113.
83. Freeman M. Rhomboid proteases and their biological functions. Annu. Rev. Genet. 2008, 42:191-210.
84. Urban S., Dickey S.W. The rhomboid protease family: a decade of progress on function and mechanism. Genome Biol. 2011, 12:231.
85. Harris P.K., Yeoh S., Dluzewski A.R., O'Donnell R.A., Withers-Martinez C., Hackett F., Bannister L.H., Mitchell G.H., Blackman M.J. Molecular identification of a malaria merozoite surface sheddase. PLoS Pathog. 2005, 1:241-251.
86. Nantakomol D., Dondorp A.M., Krudsood S., Udomsangpetch R., Pattanapanyasat K., Combes V., Grau G.E., White N.J., Viriyavejakul P., Day N.P., Chotivanich K. Circulating red cell-derived microparticles in human malaria. J. Infect. Dis. 2011, 203:700-706.
87. Nantakomol D., Palasuwan A., Soogarun S. Atomic force microscope imaging of red cell vesiculation. Eur. J. Haematol. 2011, 86:276.
88. Brown G.V., Culvenor J.G., Crewther P.E., Bianco A.E., Coppel R.L., Saint R.B., Stahl H.D., Kemp D.J., Anders R.F. Localization of the ring-infected erythrocyte surface antigen (RESA) of Plasmodium falciparum in merozoites and ring-infected erythrocytes. J. Exp. Med. 1985, 162:774-779.
89. Couper K.N., Barnes T., Hafalla J.C., Combes V., Ryffel B., Secher T., Grau G.E., Riley E.M., de Souza J.B. Parasite-derived plasma microparticles contribute significantly to malaria infection-induced inflammation through potent macrophage stimulation. PLoS Pathog. 2010, 6:e1000744.
90. Martin-Jaular L., Nakayasu E.S., Ferrer M., Almeida I.C., Del Portillo H.A. Exosomes from Plasmodium yoelii-infected reticulocytes protect mice from lethal infections. PLoS One 2011, 6:e26588.
91. Bhatnagar S., Shinagawa K., Castellino F.J., Schorey J.S. Exosomes released from macrophages infected with intracellular pathogens stimulate a proinflammatory response in vitro and in vivo. Blood 2007, 110:3234-3244.
92. Mishra S., Nussenzweig R.S., Nussenzweig V. Antibodies to Plasmodium circumsporozoite protein (CSP) inhibit sporozoite's cell traversal activity. J. Immunol. Methods 2012.
93. Prudencio M., Rodriguez A., Mota M.M. The silent path to thousands of merozoites: the Plasmodium liver stage. Nat. Rev. Microbiol. 2006, 4:849-856.
94. Jayabalasingham B., Bano N., Coppens I. Metamorphosis of the malaria parasite in the liver is associated with organelle clearance. Cell. Res. 2010, 20:1043-1059.
95. Graewe S., Rankin K.E., Lehmann C., Deschermeier C., Hecht L., Froehlke U., Stanway R.R., Heussler V. Hostile takeover by Plasmodium: reorganization of parasite and host cell membranes during liver stage egress. PLoS Pathog. 2011, 7:e1002224.
96. Chaput N., Schartz N.E., Andre F., Zitvogel L. Exosomes for immunotherapy of cancer. Adv. Exp. Med. Biol. 2003, 532:215-221.
97. Viaud S., Thery C., Ploix S., Tursz T., Lapierre V., Lantz O., Zitvogel L., Chaput N. Dendritic cell-derived exosomes for cancer immunotherapy: what's next?. Cancer Res. 2010, 70:1281-1285.
98. Aline F., Bout D., Amigorena S., Roingeard P., Dimier-Poisson I. Toxoplasma gondii antigen-pulsed-dendritic cell-derived exosomes induce a protective immune response against T. gondii infection. Infect. Immun. 2004, 72:4127-4137.
99. Franklin B.S., Vitorino B.L., Coelho H.C., Menezes-Neto A., Santos M.L., Campos F.M., Brito C.F., Fontes C.J., Lacerda M.V., Carvalho L.H. Plasma circulating nucleic acids levels increase according to the morbidity of Plasmodium vivax malaria. PLoS One 2011, 6:e19842.
100. Mott G.A., Costales J.A., Burleigh B.A. A soluble factor from Trypanosoma cruzi inhibits transforming growth factor-ss-induced MAP kinase activation and gene expression in dermal fibroblasts. PLoS One 2011, 6:e23482.
101. Cestari I., Ansa-Addo E., Deolindo P., Inal J.M., Ramirez M.I. Trypanosoma cruzi immune evasion mediated by host cell-derived microvesicles. J. Immunol. 2012, 188:1942-1952.